孙玉信教授胆心同调治疗广泛性焦虑症临床观察

《孙玉信教授胆心同调治疗广泛性焦虑症临床观察》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、河南中医学院２０１３届硕士研究生学位论文孙玉信教授胆心同调治疗广泛性焦虑症临床观察研究生姓名：刘博导师：孙玉信教授指导组成员：郭淑云教授赵文霞教授马素平教授学科、专业：中医内科学所属院、系：针灸推拿学院中国﹒郑州２０１３年４月３０日硕士学位论文原创性声明本人所呈交的硕士学位论文，是在导师孙玉信教授的指导下，独立进行科学研究工作所取得的成果。除文中已特别加以注明引用的内容外，论文中不包含任何其他个人或集体已经发表或撰写过的研究成果。对本文的研究做出重要贡献的个人和集体，均已在文中以明确方式标明并致谢。本人完全意识到本声明的法律结果由本人承担。特此声

2、明。论文作者（签名）：年月日硕士学位论文使用授权声明本人已完全了解河南中医学院有关保留、使用硕士学位论文的相关规定，同意学校保留或向国家有关部门、机构送交本学位论文的复印件和电子版，允许论文被查阅或借阅。本人授权河南中医学院可以将本论文的全部或部分内容编入有关数据库进行检索，可以采用影印、缩印或其他复制手段保存、汇编本论文（注：保密论文在解密后适用本授权声明）。特此声明。论文作者（签名）：导师（签名）：年月日年月日目录摘要·······························································

3、·····························1Abstract···························································································2前言····························································································4研究对象与方法············································

4、····································51研究对象·················································································52研究方法·················································································53诊断标准····························································

5、·····················54纳入标准·················································································65排除标准·················································································66脱落标准···········································································

6、······77治疗方法·················································································78临床观察指标···········································································79临床疗效评价···········································································7结果分析············

7、·············································································91研究对象基本资料分析·······························································92两组患者治疗前中医主要症候比较···············································113两组患者治疗前HAMA积分、中医症候积分比较····························114中医症候

8、积分及HAMA积分疗效判定···········································125不良反应观察结果·